The effect of coenzyme Q10 on sudden sensorineural hearing loss treatment

Comparison of the effect of coenzyme Q10 and placebo on the hearing status of patients with sudden sensorineural hearing loss

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20151123025202N23

Enrollment

Registered

2022-05-23

Start date

2022-05-22

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sudden sensorineural hearing loss. Sensorineural hearing loss, bilateral

Interventions

Intervention 1: Intervention group:. Intervention 2: Control group:.

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Unilateral Sudden sensorineural hearing loss Age 18-70 Years Less than one month has passed since the onset of symptoms

Exclusion criteria

Exclusion criteria: History of other ear diseases Presence of a mass or other pathology on ear MRI Conductive hearing loss

Design outcomes

Primary

Measure	Time frame
Changes in PTA and SRT auditory parameters. Timepoint: 3 and 6 months after starting treatment. Method of measurement: Through audiometry and audiogram parameters.	—

Secondary

Measure	Time frame
Hearing-related quality of life. Timepoint: 3 and 6 months after starting treatment. Method of measurement: By asking a question: Over the past week, how much has the problem of hearing loss and deafness affected your quality of life in communicating with friends, family and colleagues? And responses on the Likert scale will range from very low to very high.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbbas Moradi

Hamedan University of Medical Sciences

a.moradi@umsha.ac.ir+98 81 3838 0557

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026